INTRODUCTION
Our patient, a term infant, was diagnosed with Kartagener syndrome in the early neonatal period following presentation with unexplained respiratory distress and situs viscerum inversus. This allowed for early initiation of physiotherapy and multidisciplinary treatment and follow up.
CASE REPORT
A 3.56-kg term male infant was born by cesarean section to a 24-year-old gravida 2 para 1 mother. Prenatal screens were unremarkable. Apgar scores were 10 and 10 at 1 and 5 minutes, respectively. In the very fi rst hours of life, the newborn was noted to have nasal congestion, cough and tachypnea, increasing his work of breathing within hours. He was admitted to the neonatal intensive care unit. White cell count was normal, C-reactive protein slightly elevated (24.9 mg/L), blood cultures and nasopharyngeal aspirate were negative. Chest radiograph revealed atelectasis at the right middle lobe and dextrocardia. Echocardiogram revealed dextrocardia with open foramen ovale. Abdominal sonography confi rmed situs viscerum inversus. Antibiotics were started and administered for 5 days. He continued to have respiratory distress and required oxygen during the fi rst 8 days. Until the day of discharge (postnatal day 22), he continued to have thick nasal mucus with cough, so he required frequent nasal discharge, saline inhalations and chest physiotherapy. Nasal ciliary biopsy was also performed. Electron microscopy of the nasal cilia demonstrated qualitative and quantitative abnormalities of kinocilia, suggesting primary ciliary dyskinesia: normal 9+2 arrangement of the microtubules but with a reduced number of the outer and inner dynein arms, shorter cilia and abnormal ciliary orientation. Prior to discharge, multidisciplinary follow up was arranged.
DISCUSSION
Kartagener syndrome (KS) is a rare heterogeneous autosomal recessive disease. The prevalence of KS is 1 case per 32,000 live births (1). KS is a type of primary ciliary dyskinesia (PCD) associated with situs viscerum inversus. PCD can result from mutations in many diff erent genes.
Although much progress in gene identifi cation for PCD has been achieved, it has been recently estimated that the RIBIČIĆ R. ET AL. KARTAGENER SYNDROME.
known genes in which mutations cause PCD account for about 65% of PCD cases. Mutations in the DNAI1 and DNAH5 genes account for up to 30% of all PCD cases (2) .
In an attempt to identify additional PCD causing mutations, one of the newest studies by Hjeij et al. revealed loss-offunction mutations in CCDC151 in three unrelated families characterized by PCD with specifi c loss of the outer dynein arms and severely impaired ciliary beating (3). In many cases of PCD, the cause of the disorder is unknown. Mutations in the genes that cause PCD result in defective cilia that move abnormally or are immotile. Defective embryonal monocilia are thought to cause random organ rotation during embryonal period. As a result, approximately 50% of PCD patients have situs inversus, and the other half of PCD patients have normal situs viscerum. Symptoms of PCD may start in early childhood and the mean age at diagnosis is 4.4 years (4). However, the diagnosis is often missed and symptomatic treatment for recurrent upper and lower respiratory tract infections is off ered in most cases. A history of onset of respiratory symptoms in the neonatal period in children with chronic respiratory problems is strongly suggestive of PCD. Seventy-six percent of those children have neonatal history of persistent rhinitis, 67% neonatal respiratory distress and 69% situs inversus (4) . Approximately 12% of aff ected children have complex congenital heart disease. Because of impaired mucociliary clearance, infants with PCD have a major risk of recurrent, chronic infections of the lungs, middle ear and paranasal sinuses. Also, male infertility and defects in neutrophil chemotaxis can be present (5) . Ciliated epithelium covers most areas of the upper and lower respiratory tract, reproductive organs and ependyma. The typical ciliary axoneme consists of 2 central microtubules surrounded by 9 microtubular doublets comprised of an A and a B subunit. There are several proteins described (nexin as most important) that interconnect the outer doublets to each other, and the inner and outer dynein arms. Each A subunit is attached do 2 dynein arms that contain adenosine triphosphate (ATP). The basic mechanism for ciliary motion is mediated by dynein arm of one A subunit that is attached to the dynein arm of the adjacent B subunit. ATP is hydrolyzed by the dynein arms and 9 microtubule doublets as they slide against each other. Patients with PCD have a wide range of defects in ciliary ultrastructure and motility, which ultimately impairs ciliary beating and mucociliary clearance. The most common defect is reduction in the number of dynein arms (over 95% of cases), but absent radial spokes and central tubules, transposed doublets, abnormal basal cell apparatus, cilia with abnormal length and normal ciliary ultrastructure with abnormal arrangement and beat direction can also be found (6) . Diagnostic tests include imaging studies, saccharine and nitric oxide tests, pulmonary function studies, but the only standardized defi nitive diagnostic test to visualize ciliary ultrastructure is nasal mucosa brushing or biopsy and bronchial mucosa biopsy, which are obtained for electron microscopy, (7) .
The classic PCD symptoms may not be present in the neonatal period, but neonatologist should consider the diagnosis of PCD or KS in a newborn with prolonged or recurrent or unexplained respiratory distress or pneumonia, oxygen dependence, atelectasis, thick nasal mucus and productive cough, especially when situs inversus totalis is present. It is very important to make the diagnosis as early as possible, as regular physiotherapy and postural drainage may prevent recurrent respiratory infections and progression to bronchiectasis. 
